2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Histiocytic Sarcoma: new trials by email Literature Review of Histiocytic Sarcoma trials Research Report on Histiocytic Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration and Biopsy - Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 1377 | 2017-07-31 | 2026-07-24 |
| Lenalidomide for Adult Histiocyte Disorders Lenalidomide - Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease | Phase 2 | Active not recruiting | Dana-Farber Cancer Institute | 12 | 2015-08-01 | 2026-07-23 |
Histiocytosis, Langerhans-Cell (2) · Central Nervous System Neoplasms (1) · Ependymoma (1) · Erdheim-Chester Disease (1) · Glioma (1) · Hepatoblastoma (1) · Lymphoma, Non-Hodgkin (1) · Medulloblastoma (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Osteosarcoma (1) · Rhabdoid Tumor (1) · Rhabdomyosarcoma (1) · Sarcoma (1)
Hemic and Lymphatic Diseases (2) · Histiocytic Disorders, Malignant (2) · Histiocytosis (2) · Histiocytosis, Non-Langerhans-Cell (2) · Lung Diseases (2) · Lung Diseases, Interstitial (2) · Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Respiratory Tract Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Immune System Diseases (1)
Biopsy (1) · LY3023414 (1) · Lenalidomide (1) · Magnetic Resonance Spectroscopy (1) · Nuclear Medicine Department, Hospital (1) · Phantoms, Imaging (1) · Specimen Handling (1) · Vemurafenib (1) · X-Rays (1) · ensartinib (1) · erdafitinib (1) · ivosidenib (1) · larotrectinib (1) · olaparib (1) · palbociclib (1)
Dana-Farber Cancer Institute (1) · National Cancer Institute (NCI) (1)
United States (2) · Australia (1) · Canada (1) · Puerto Rico (1)
Donald W Parsons (1) · Eric Jacobsen, MD (1)
PMID 33591402, PMID 35353553, PMID 41166674, PMID 42686334
U10CA180886 (1)